Stocktoria
MEDICINOVA INC MNOV
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2006-12-01
MEDICINOVA INC statistics & valuation
Market cap$65.0M
P / B1.6×
Net margin-2928.8%
Return on equity-28.9%
FCF margin-2395.4%
Return on capital-31.8%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -3242.5% | — | -990.0% | — | -253.0% | — | — | — | — | — |
| Net margin | -2928.8% | — | -857.2% | — | -251.0% | — | — | — | — | — |
| FCF margin | -2395.4% | — | -745.2% | — | -233.1% | — | — | — | — | — |
| Return on assets | -26.3% | -19.8% | -12.9% | -19.0% | -11.6% | -18.4% | -16.3% | -19.0% | -25.7% | -27.3% |
| Return on equity | -28.9% | -21.0% | -13.7% | -20.0% | -12.1% | -19.4% | -17.3% | -20.1% | -28.9% | -31.5% |
| Current ratio | 8.16 | 13.88 | 15.61 | 18.51 | 25.42 | 27.67 | 28.86 | 28.63 | 9.83 | 15.16 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.